Replacing one serving of sugary drink every day may lower diabetes risk
the ONA take:
According to research published in the journal Diabetologia, researchers have found that replacing one serving of a sugary drink per day with water, unsweetened tea, or coffee can reduce the risk of developing type 2 diabetes by 14 to 25%.
Specifically, researchers found that replacing a serving of a soft drink with water, unsweetened tea, or coffee cuts the risk of diabetes by 14%. Replacing a serving of a sweetened milk beverage with either of the three reduces the risk by 20-25%.
The study also showed that for each 5% of higher intake of energy from total sweet beverages was linked with an 18% increased risk for diabetes.
The researchers determined that if participants had decreased the energy they obtained from sweet beverages to below 2% of total daily energy, 15% of new diabetes cases could be avoided.
"Our new findings on the potential to reduce the burden of diabetes by reducing the percentage of energy consumed from sweet beverages add further important evidence to the recommendation from the World Health Organization to limit the intake of free sugars in our diet," lead researcher Dr. Nita Forouhi, of the UK Medical Research Council Epidemiology Unit, University of Cambridge, said.
Replacing one serving of a sugary drink per day with water, unsweetened tea, or coffee can reduce the risk of developing type 2 diabetes
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|